Europe needs to catch up with psychedelic research

A recent PAREA editorial written by Professor David Nutt highlights that despite Europe once leading the psychedelic research field, we are now lagging behind the Americas and Australia in turning this science into clinical practice.

Read how the US, Canada and Australia are outpacing Europe.

Previous
Previous

PAREA submits feedback on EU mental health initiative

Next
Next

The Therapeutic Potential of Psychedelics: The European Regulatory Perspective